BSA
ZBH icon

Braun Stacey Associates’s Zimmer Biomet ZBH Stock Holding History

Braun Stacey Associates’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-107,760
Closed -$16.8M – 143
2021
Q2 		$16.8M Buy
107,760
+4,174
+4% +$676K 0.66% 77
2021
Q1 		$16.1M Buy
103,586
+19,511
+23% +$3.02M 0.68% 77
2020
Q4 		$12.6M Buy
+84,075
New +$11.9M 0.56% 87

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Braun Stacey Associates's ZBH Position: Q3 2021 in Review

Braun Stacey Associates sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 107,760 shares — an estimated $16.8M sold.

Braun Stacey Associates first reported a position in ZBH in Q4 2020 and held it in 3 quarters. The position peaked at $16.8M in Q2 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

  • Braun Stacey Associates reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
  • Braun Stacey Associates sold 107,760 Zimmer Biomet shares in Q3 2021, an estimated $16.8M.
  • Braun Stacey Associates first reported a position in Zimmer Biomet in Q4 2020 and held it in 3 quarters.
  • Braun Stacey Associates's Zimmer Biomet position peaked at $16.8M in Q2 2021.
  • 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Braun Stacey Associates's 13F filing for Q3 2021, filed 1 Dec 2021.